Last reviewed · How we verify
Allergic Keratoconjunctivitis
Approved treatments
- Intal · Pfizer
- Cromoglicate · LEO Pharma
- Cromoglycate · Vishwajit Nimgaonkar, MD PhD
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Allergic Keratoconjunctivitis patent landscape — cliff calendar, originator estates, attackable patents
- Allergic Keratoconjunctivitis treatment landscape brief
- Allergic Keratoconjunctivitis treatment updates RSS
Frequently asked questions about Allergic Keratoconjunctivitis
What drugs treat Allergic Keratoconjunctivitis?
Tracked treatments include Intal, Cromoglicate, Cromoglycate.
What is the treatment for Allergic Keratoconjunctivitis?
Standard treatment for Allergic Keratoconjunctivitis includes Intal, Cromoglicate, Cromoglycate. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Allergic Keratoconjunctivitis patent cliff · Allergic Keratoconjunctivitis CI report
- Treatment: Intal · Pfizer
- Treatment: Cromoglicate · LEO Pharma
- Treatment: Cromoglycate · Vishwajit Nimgaonkar, MD PhD
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing